Barcelonabeta Brain Research Center

The medical center is at the forefront of research in neurodegenerative diseases, with a particular focus on Alzheimer's Disease. The institution is actively involved in exploring innovative therapies aimed at slowing cognitive decline in patients with preclinical stages of the disease.

• Phosphorylated Tau Targeted Active Immunotherapy
• Preclinical Alzheimer's Disease Cognitive Assessment

Through its cutting-edge research, the center is contributing to the development of targeted immunotherapies that aim to modify disease progression by addressing specific pathological markers.

Specializing in the study of amyloid accumulation in Alzheimer's Disease, the center is conducting advanced clinical trials to evaluate the efficacy of novel treatments. These studies focus on reducing amyloid levels in the brain, which is a hallmark of Alzheimer's pathology.

• Reduction of Brain Amyloid Accumulation
• Long-term Safety and Tolerability Studies

The center's research is pivotal in understanding the role of amyloid in Alzheimer's and developing therapies that could potentially alter the course of the disease.